The effect of renal impairment and obesity on anti-Xa peak and trough levels in patients receiving therapeutic doses of nadroparin: a comparison with control patients

PURPOSE: Anti-Xa peak level monitoring is recommended during LMWH treatment in renal impairment or obesity. The trough level has been proposed as marker for bleeding. We studied the influence of renal impairment and obesity on anti-Xa levels. METHODS: Peak and trough levels were collected during the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mast, L., Peeters, M. Y. M., Söhne, M., Hackeng, C. M., Knibbe, C. A. J., van den Broek, M. P. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618299/
https://www.ncbi.nlm.nih.gov/pubmed/37707559
http://dx.doi.org/10.1007/s00228-023-03558-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618299/
https://www.ncbi.nlm.nih.gov/pubmed/37707559
http://dx.doi.org/10.1007/s00228-023-03558-5

Ejemplares similares